In vivo study further validated that treatment with BLZ‐945SCNs/Pt greatly decrease the TAM population and increase CD8+ T cells, leading to significant suppression of tumor growth in 4T1 breast tumor‐bearing mice model. The gene discussed is CD8A; the disease is breast neoplasm.